Upcoming events – Beacons of hope for Array and Proteon - Vantage

Upcoming events – Beacons of hope for Array and Proteon  VantageArray Biopharma hopes for a label extension for its Braf/Mek inhibitor, and Proteon tries to make a better fist of its second phase III trial of vonapanitase.